Cervical cancer is the third most common cancer in women worldwide, affecting over 500,000 women and resulting in approximately 275,000 deaths every year.
The American Cancer Society estimates 95% of cervical cancer could be prevented or effectively cured with regular screening.
But in the United States, ~4,000 women die every year from cervical cancer and it is estimated that ~30% of U.S. women do not receive regular screenings according to the CDC.
Learn more about cervical cancer here.
Genentech has led three efforts to alter cervical cancer’s trajectory: